Urolithin A is a postbiotic compound produced when gut bacteria metabolize ellagitannins—plant polyphenols found in berries, pomegranates, and nuts—into a bioactive form that can be absorbed and utilized by human cells.
Mechanism of action
Urolithin A activates mitophagy, the selective autophagy pathway that removes damaged or dysfunctional mitochondria, thereby promoting mitochondrial quality control and cellular energy metabolism. The mechanism appears to involve calcium-dependent signaling that modulates inter-organellar communication. This mitochondrial housekeeping process may enhance cellular resilience during aging and metabolic stress. Evidence suggests these effects occur through p62-dependent lysophagy pathways and downstream mitochondrial transcriptomic changes.
Evidence overview
Multiple randomized controlled trials and mechanistic studies support urolithin A's role as a mitophagy inducer with potential longevity relevance. A key RCT demonstrated effects on age-related immune function, and preclinical studies show urolithin A modulates inter-organellar calcium signaling to promote mitochondrial quality control, reduces anxiety-related behaviors while rescuing mitochondrial gene expression in animal models, and improves cardiovascular health biomarkers in humans. Supporting evidence includes studies on retinal neuroprotection via lysophagy induction and microglial immune regulation. The evidence base is predominantly moderate to strong in mechanistic studies and RCT design, though human longevity outcome data remains limited. Some in vitro studies show neutral or nuanced effects on immune cell metabolism, indicating that effects may be cell-type or context dependent.
Content overview generated by AI from pipeline evidence. Not medical advice — consult a licensed physician. Generated 2026-08-25.
Precursor chain
Research citations
Citations link to peer-reviewed publications. Virisource is not affiliated with any author or institution. Not medical advice.
Recent research mentioning Urolithin A
- Urolithin A counteracts cyclophosphamide-induced chemobrain in rats through modulation of mitochondrial signaling pathways.Labib AY, Assal RA, Mantawy EM, Tadros MG, Michel HE · J Ethnopharmacol · 2026-04-02pubmed
Continuously updated by the research discovery pipeline. New citations appear automatically within a day of publication.
How it works
Urolithin A is a metabolite compound resulting from the transformation of ellagitannins by the gut bacteria.
Source: Wikipedia
Chemistry
- IUPAC name
- 3,8-dihydroxybenzo[c]chromen-6-one
- Formula
- C13H8O4
- PubChem
- CID 5488186 →
Source: PubChem (NIH, public domain)
Learn more
Related compounds
Explore more in mitophagy
Ellagitannins
mitophagyDiscover 3 whole food sources of Ellagitannins, certified organic growers, and the latest longevity research on this bio…
NAD+ precursors
NAD+ precursors: longevity research, bioavailability, and emerging evidence from peer-reviewed studies.
Metformin
Metformin: longevity research, bioavailability, and emerging evidence from peer-reviewed studies.
Coenzyme Q10 (Ubiquinol)
mitochondrialLipid-soluble electron carrier in the mitochondrial electron transport chain, present in organ meats, sardines, mackerel…
Choline
methylationEssential nutrient from eggs, liver, soybeans, and fish. Precursor to acetylcholine and the methyl donor betaine; critic…